RE
RepliCel Life Sciences Inc.
REPCF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $10.4K
P/E Ratio 0.00x
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Trenutna cena
$0.0001
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica REPCF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/S 0.02x
P/E 0.00x
EV/EBITDA 2.10x
Growth
20 /100
Declining Rev. growth 0.03%
Book val. growth N/A
EPS growth N/A
Profitability
54 /100
Moderate Op. margin 102.80%
Gross margin 16.67%
FCF margin 25.56%
Quality
43 /100
Average Asset turnover 6.56x
ROIC 71.76%
ROA 9,551.74%
Debt
54 /100
Moderate Net debt/EBITDA 2.08x
Current ratio 0.02x
Int. coverage 9.37x
Stability
53 /100
Moderate EPS volatility 192.82%
Beta 0.56x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o REPCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Schutte
Employees
1
Headquarters
Vancouver